Meeting slides
Suggested Readings

Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial.

Amanyire G, et al. Lancet HIV. 2016;3(11):e539-e548.

Antiretroviral therapy for the prevention of HIV-1 transmission.

Cohen MS, et al. N Engl J Med. 2016;375(9):830-839.

Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen MS, et al. N Engl J Med. 2011;365(6):493-505.

A rapid entry program in the south: improving access to care and viral suppression.

Colasanti J. 25th Conference on Retroviruses and Opportunistic Infections (CROI) 2018. March 4−7, 2018; Boston, MA. Poster 1109.

Continuous retention and viral suppression provide further insights into the HIV care continuum compared to the cross-sectional HIV care cascade.

Colasanti J, et al. Clin Infect Dis. 2016;62(5):648-654.

Linkage and antiretroviral therapy within 72 hours at a federally qualified health center in New Orleans.

Halperin J, et al. AIDS Patient Care STDS. 2018;32(2):39-41.

Rapid HIV care cuts time to viral suppression in half.

Schoen J, et al. Healio Infectious Disease News. 2018.

Initiation of antiretroviral therapy in early asymptomatic HIV infection.

INSIGHT START Study Group. N Engl J Med. 2015;373(9):795-807.

Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: a randomized unblinded trial.

Koenig S, et al. PLoS Med. 2017;14(7):e1002357.

Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in Lesotho: the CASCADE randomized clinical trial.

Labhardt ND, et al. JAMA. 2018;319(11):1103-1112.

Association of implementation of a universal testing and treatment intervention with HIV diagnosis, receipt of antiretroviral therapy, and viral suppression in East Africa.

Peterson M, et al. JAMA. 2017;317(21):2196-2206.

The effect of same-day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a U.S. public health setting.

Pilcher CD, et al. J Acquir Immune Defic Syndr. 2017;74(1):44-51.

Initiating antiretroviral therapy for HIV at a patient’s first clinic visit: the RapIT randomized controlled trial.

Rosen S et al. PLoS Med. 2016;13(5):e1002015.

Trends in the San Francisco human immunodeficiency virus epidemic in the "Getting to Zero" era.

Scheer S, et al. Clin Infect Dis. 2018;66(7):1027-1034.

A trial of early antiretrovirals and isoniazid preventive therapy in Africa.

TEMPRANO ANRS 12136 Study Group. N Engl J Med. 2015;373(9):808-822.

Pooled week 48 efficacy and baseline resistance: B/F/TAF in treatment-naïve patients.

White KL, et al. 25th Conference on Retroviruses and Opportunistic Infections (CROI), 2018. March 4−7, 2018; Boston, MA Abstract 532.

Linked Resources

Clinical Practice Guidelines

Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy.

World Health Organization, 2017.

Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living With HIV.

US Department of Health and Human Services, 2017 (last updated March 2018).

HIV Testing Guidelines.

Centers for Disease Control and Prevention, 2018.

Clinical Resources

90–90–90: An Ambitious Treatment Target to Help End the AIDS Epidemic.

Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014.


Emory University Rollins School of Public Health, Gilead Sciences, Inc., and the Center for AIDS Research at Emory University (CFAF), 2018.

Database of Antiretroviral Drug Interactions.

HIV InSite. University of California, San Francisco, 2018.

Harm Reduction Coalition.


HEP Drug Interactions.

University of Liverpool, 2018.

Patient Resources

Centers for Disease Control and Prevention (CDC): HIV Basics

The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This comprehensive site provides extensive links to topics across the HIV-care continuum, including PrEP.

Project Inform

Project Inform provides up-to-date information to help people living with HIV and HCV make the best choices regarding their treatment and care.

Hepatitis C and HIV Coinfection Booklets

Sex-C: Sex and Hepatitis C Prevention Tips for Gay Men

Sexual Transmission of Hepatitis C: A Guide for HIV-Positive Gay Men

Positively Aware

Positively Aware, created by TPAN (Test Positive Aware Network), is a source of HIV-treatment news for consumers, as well as an educational tool for HIV caregivers. The site features PrEP resources, including videos for MSM and transgender people.

Smartphone Pill Reminder Apps (Free)

Mango Health — Medicine Manager, Pill Reminder for iPhone

Mango Health for Android

Medisafe Pill Reminder, RX and Medicine Tracker for iPhone

Medisafe Meds and Pill Reminder for Android

Related activities
0.25 CME/CE

Initiating HIV Therapy

Are We Now in an Integrase-Based World?

Faculty: Paul E. Sax, MD; Ian Frank, MD
Release: 06/01/2018
Expiration: 06/01/2019
0.25 CME/CE

Management of Patients With Virologic Suppression

Evaluating Switching Strategies of Today and Tomorrow

Faculty: Paul E. Sax, MD; Ian Frank, MD
Release: 07/10/2018
Expiration: 07/10/2019
1.00 CME/CE

HIV Experts & Evidence™

Evolving Models of HIV Care (Volume 1) - Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

Faculty: Johnathan A. Colasanti, MD, MSPH; Paul E. Sax, MD
Release: 12/20/2018
Expiration: 12/20/2019